Item | Information |
---|---|
CAS RN | 113-92-8 |
Chemical Name | Chlorpheniramine maleate |
Substance ID | m-nite-113-92-8_v1 |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | To Guidance List |
UN GHS document (External link) | To UN GHS document |
FAQ(GHS classification results by the Japanese Government) | To FAQ |
List of Information Sources (Excel file) | List of Information Sources |
List of Definitions/Abbreviations | Definitions/Abbreviations |
Sample Label by MHLW (External link) | To Workplace Safety Site (MHLW) |
Sample SDS by MHLW (External link) | To Workplace Safety Site (MHLW) |
OECD/eChemPortal (External link) | To OECD/eChemPortal (External link) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Explosives | Not classified (Not applicable) |
- |
- | - | There are no chemical groups associated with explosive properties present in the molecule. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
2 | Flammable gases | Not classified (Not applicable) |
- |
- | - | "Solids" according to GHS definition. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
3 | Aerosols | Not classified (Not applicable) |
- |
- | - | Not an aerosol product. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
4 | Oxidizing gases | Not classified (Not applicable) |
- |
- | - | "Solids" according to GHS definition. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
5 | Gases under pressure | Not classified (Not applicable) |
- |
- | - | "Solids" according to GHS definition. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
6 | Flammable liquids | Not classified (Not applicable) |
- |
- | - | "Solids" according to GHS definition. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
7 | Flammable solids | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
8 | Self-reactive substances and mixtures | Classification not possible |
- |
- | - | There is a chemical group present in the molecule associated with a self-reactive property (unsaturated bond), but the classification is not possible due to no data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
9 | Pyrophoric liquids | Not classified (Not applicable) |
- |
- | - | "Solids" according to GHS definition. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
10 | Pyrophoric solids | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
11 | Self-heating substances and mixtures | Classification not possible |
- |
- | - | No established test method suitable for solid substances with a melting point of 140 degrees C or lower. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
12 | Substances and mixtures which, in contact with water, emit flammable gases | Not classified (Not applicable) |
- |
- | - | Not containing metals or semimetals (B, Si, P, Ge, As, Se, Sn, Sb, Te, Bi, Po, At). | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
13 | Oxidizing liquids | Not classified (Not applicable) |
- |
- | - | "Solids" according to GHS definition. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
14 | Oxidizing solids | Not classified (Not applicable) |
- |
- | - | It contains oxygen and chlorine which are not chemically bonded to elements other than carbon or hydrogen. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
15 | Organic peroxides | Not classified (Not applicable) |
- |
- | - | An organic compound that does not contain -O-O- structure. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
16 | Corrosive to metals | Classification not possible |
- |
- | - | No established test method suitable for solid substances. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
17 | Desensitized explosives | - |
- |
- | - | - | - | - |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Category 4 |
Warning |
H302 | P301+P312 P264 P270 P330 P501 |
It was classified in Category 4 to which most of the three LD50 data for rats (118 mg/kg, 540 mg/kg, 680 mg/kg (above NTP TR317 (1986)) correspond, one of which corresponds to Category 3 and two correspond to Category 4. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Dermal) | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Inhalation: Gases) | Not classified (Not applicable) |
- |
- | - | "Solids" according to GHS definition. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Inhalation: Vapours) | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Inhalation: Dusts and mists) | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
2 | Skin corrosion/irritation | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
3 | Serious eye damage/eye irritation | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
4 | Skin sensitization | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
5 | Germ cell mutagenicity | Not classified |
- |
- | - | From a negative result in a micronucleus test using bone marrow cells after intraperitoneal administration in mice (in vivo somatic cell mutagenicity test) (NTP DB (1993)), it was classified as "Not classified." Besides, as in vitro tests, results of negatives in an Ames test (NTP DB (1982)) and a mouse lymphoma test (NTP DB (Access on May 2011)) and a positive in a chromosomal aberration test using CHO cells in the presence of metabolic activation (NTP DB (Access on May 2011)) were reported. |
FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
6 | Carcinogenicity | Not classified |
- |
- | - | In a 103-week oral administration test in rats and mice, it was reported that no evidence of carcinogenicity in either species of either sex was found, though decreased body weights in dosed groups and decreased survival rates in high-dose female rats and high-dose male mice at the end of the test were observed. (NTP TR317 (1986)) Therefore, it was classified as "Not Classified." Besides, reduction of the sensitivity to detect a carcinogenic response due to high mortality in high-dose female rats and high-dose male mice, and proliferative changes by increased incidences of thyroid gland follicular cell cysts and hyperplasia in female mice were reported. |
FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
7 | Reproductive toxicity | Category 2 |
Warning |
H361 | P308+P313 P201 P202 P280 P405 P501 |
In an oral administration test using rats, in which males were dosed from 63 days before mating through a mating period, and females were dosed from 21 days before mating until day 14 of gestation or 21 days after parturition, no effects on sexual function and fertility, but an increased percentage of deaths in offspring during a lactation period were observed (NTP TR317 (1986)). Furthermore, mice had 100% of abortion or resorption during a gestation period by oral administration in the highest dose group, and fetuses showed marked decreases in survival rate at the end of gestation or after delivery at doses lower than the highest. (NTP TR317 (1986)) Due to no description of general toxicity in parent animals, it was classified in Category 2 based on the above. Besides, in an oral administration test during an organogenetic period in rats and rabbits, no adverse effects on the development of the offspring including teratogenicity were reported. (NTP TR317 (1986)) |
FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
8 | Specific target organ toxicity - Single exposure | Category 1 (central nervous system) |
Danger |
H370 | P308+P311 P260 P264 P270 P321 P405 P501 |
This substance is used as an antihistamine medicine (H1 receptor antagonist), and the H1 receptor antagonist is known to cause excitement or depression of central nervous system. (NTP TR317 (1986)) Convulsions and confusions are listed as serious adverse effects, and sedation, nervousness, sleepiness, dizziness, tremor, coordination abnormality and so on are listed as other adverse effects in a neuropsychiatric system in the drug package insert. (Ethical pharmaceuticals (2010), corresponding to List 1) And acute poisoning with H1 receptor antagonists, which show symptoms of hallucinations, excitement, ataxia, incoordination, athetosis, and convulsions, could cause very dangerous situations by their central nervous stimulation. (HSDB (2003)) From the above knowledge in human, it was classified in Category 1 (central nervous system). Besides, also in experimental animals, excitement, muscle tremor, ataxia, and convulsive seizures were reported as symptoms in an acute toxicity test using rats and mice. (NTP TR317 (1986)) |
FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
9 | Specific target organ toxicity - Repeated exposure | Category 1 (central nervous system, cardiovascular system, hematopoietic system) |
Danger |
H372 | P260 P264 P270 P314 P501 |
This substance is used as an antihistamine medicine (H1 receptor antagonist), and the H1 receptor antagonist is known to cause excitement or depression of central nervous system. (NTP TR317 (1986)) Convulsions and confusions are listed as serious adverse effects, and sedation, nervousness, sleepiness, dizziness, tremor, coordination abnormality and so on are listed as other adverse effects in a neuropsychiatric system in the drug package insert. (Ethical pharmaceuticals (2010)) Besides, in animal tests, in oral administration in rats and mice for 2, 13, or 104 weeks, hyperactivity, hyperexcitability, and lethargy were observed, and convulsions, tremor, and loss of coordination in addition to deaths were reported at a high dose. (NTP TR317 (1986)) By taking as a target organ from the above results, it was classified in Category 1 (central nervous system). In the second place, in 104-week oral administration in monkeys, decreased heart rates, and prolonged duration of electrical systole at 10 mg/kg/day corresponding to Category 1 in Guidance values or higher, and deaths by cardiac failure in addition to arrhythmias and fainting at 15 mg/kg/day occurred. (NTP TR317 (1986)) Serious adverse effects such as shock, cyanosis, dyspnea, angina pectoris, and hypotension are listed in medical use in humans. (Ethical pharmaceuticals (2010)) Therefore, it was classified in Category 1 (cardiovascular system). There are case reports, moreover, that show association with thrombocytopenic purpura, bone marrow suppression, and aplastic anemia (NTP TR317 (1986)), and aplastic anemia and agranulocytosis are listed as serious adverse effects (Ethical pharmaceuticals (2010)). Therefore it was classified in Category 1 (hematopoietic system). From the above, it is classified in Category 1 (central nervous system, cardiovascular system, hematopoietic system). |
FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
10 | Aspiration hazard | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment Short term (Acute) | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
11 | Hazardous to the aquatic environment Long term (Chronic) | Classification not possible |
- |
- | - | No data. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
12 | Hazardous to the ozone layer | Classification not possible |
- |
- | - | This substance is not listed in Annexes to the Montreal Protocol. | FY2011 | GHS Classification Guidance by the Japanese Government (July, 2010) |
|